Published in Clin Neuropharmacol on December 22, 2004
A gender-related action of IFNbeta-therapy was found in multiple sclerosis. J Transl Med (2012) 0.79
Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis. Immunology (2006) 0.78
Migraine and hemorrhagic stroke: a meta-analysis. Stroke (2013) 3.08
Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke (2005) 3.07
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol (2012) 2.77
Incidence and 10-year survival of intracerebral hemorrhage in a population-based registry. Stroke (2008) 1.72
The Italian version of the Coma Recovery Scale-Revised (CRS-R). Funct Neurol (2007) 1.48
Migraine in women: the role of hormones and their impact on vascular diseases. J Headache Pain (2012) 1.40
Restarting oral anticoagulants after intracerebral hemorrhage: cons. Intern Emerg Med (2014) 1.39
Spreading depolarization may link migraine, stroke, and other cardiovascular disease. Headache (2014) 1.16
Comorbid neuropathologies in migraine. J Headache Pain (2006) 1.09
Comorbid neuropathologies in migraine: an update on cerebrovascular and cardiovascular aspects. J Headache Pain (2008) 1.05
Migraine and vascular diseases: a review of the evidence and potential implications for management. Cephalalgia (2012) 1.00
Epidemiology of stroke in Italy. Int J Stroke (2011) 0.99
Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study. Cerebrovasc Dis (2010) 0.99
Management of pathologic laughter and crying in patients with locked-in syndrome: a report of 4 cases. Arch Phys Med Rehabil (2008) 0.98
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. BMC Neurol (2012) 0.94
CADASIL presenting as status migrainosus and persisting aura without infarction. J Headache Pain (2008) 0.93
CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response. Transpl Immunol (2003) 0.93
Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes. J Neuroimmunol (2006) 0.92
Heart rate non linear dynamics in patients with persistent vegetative state: a preliminary report. Brain Inj (2008) 0.91
Diagnostic criteria for CADASIL in the International Classification of Headache Disorders (ICHD-II): are they appropriate? J Headache Pain (2010) 0.90
Stroke tracked by administrative coding data: is it fair? Stroke (2013) 0.89
Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol (2011) 0.89
Passage from normal mucosa to adenoma and colon cancer: alteration of normal sCD30 mechanisms regulating TH1/TH2 cell functions. Cancer Biother Radiopharm (2003) 0.86
Associations between HLA class I alleles and the prevalence of nasopharyngeal carcinoma (NPC) among Tunisians. J Transl Med (2007) 0.86
The prevalence of multiple sclerosis in central Italy. Mult Scler (2010) 0.85
Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study). J Hypertens (2011) 0.85
ICHD-II criteria for headache attributed to transient ischemic attack: the need for an update. Cephalalgia (2010) 0.85
Epidural analgesia and cesarean delivery in multiple sclerosis post-partum relapses: the Italian cohort study. BMC Neurol (2012) 0.84
Migraine attributed to genetic disorder. Funct Neurol (2007) 0.84
HLA typing does not predict REM sleep behaviour disorder and hallucinations in Parkinson's disease. Mov Disord (2003) 0.84
Contribution of hematocrit to early mortality after ischemic stroke. Eur Neurol (2007) 0.83
Behavioral therapy for chronic migraine. Curr Pain Headache Rep (2013) 0.83
Peripheral vascular dysfunction in migraine: a review. J Headache Pain (2013) 0.83
Incidence, case-fatalities and 10-year survival of subarachnoid hemorrhage in a population-based registry. Eur Neurol (2009) 0.82
Vegetative states and minimally conscious states revisited: a Russian doll approach. Brain Inj (2013) 0.81
The study of a patient's immune system may prove to be a useful noninvasive tool for stage classification in colon cancer. Cancer Biother Radiopharm (2006) 0.81
Post-transplant donor-specific antibody production and graft outcome in kidney transplantation: results of sixteen-year monitoring by flow cytometry. Clin Transpl (2006) 0.81
Are immunological mechanisms involved in colon cancer and are they possible markers for biotherapy improvement? Cancer Biother Radiopharm (2006) 0.81
Gender-specific cytokine pathways, targets, and biomarkers for the switch from health to adenoma and colorectal cancer. Clin Dev Immunol (2011) 0.80
Evidence of redox unbalance in post-acute ischemic stroke patients. Curr Neurovasc Res (2012) 0.80
Atherothrombotic burden and medium-term prognosis in patients with acute ischemic stroke: findings of the SIRIO study. Cerebrovasc Dis (2012) 0.79
Challenges to the management of high-risk stroke patients with multiple-site occlusive vascular disease. Cerebrovasc Dis (2011) 0.79
Oxidative stress in post-acute ischemic stroke patients after intensive neurorehabilitation. Curr Neurovasc Res (2012) 0.79
A gender-related action of IFNbeta-therapy was found in multiple sclerosis. J Transl Med (2012) 0.79
Ageing gender-specific "Biomarkers of Homeostasis", to protect ourselves against the diseases of the old age. Immun Ageing (2014) 0.79
Peripheral blood immunological parameters for use as markers of pre-invasive to invasive colorectal cancer. Cancer Biother Radiopharm (2002) 0.79
Morphological variations of the internal carotid artery: Prevalence, characteristics and association with cerebrovascular disease. Int J Angiol (2007) 0.79
Stroke in Italy: a disease to prevent. Clin Exp Hypertens (2006) 0.79
Showered cortical infarctions and brain atrophy in Churg-Strauss syndrome. Eur Neurol (2011) 0.79
Intrathecal baclofen: effects on spasticity, pain, and consciousness in disorders of consciousness and locked-in syndrome. Curr Pain Headache Rep (2015) 0.78
MICA polymorphism in a population from north Morocco, Metalsa Berbers, using sequence-based typing. Hum Immunol (2005) 0.78
Ethical aspects of vegetative and minimally conscious states. Curr Pharm Des (2014) 0.78
Corticomotor facilitation in vegetative state: results of a pilot study. Arch Phys Med Rehabil (2013) 0.78
Colon cancer and gene alterations: their immunological implications and suggestions for prognostic indices and improvements in biotherapy. Cancer Biother Radiopharm (2006) 0.78
Prolongation of TCD-enhanced Doppler signal by continuous infusion of levovist. Ultrasound Med Biol (2002) 0.78
Tension-type headache and systemic medical disorders. Curr Pain Headache Rep (2011) 0.78
Validation of the Italian version of a new coma scale: the FOUR score. Intern Emerg Med (2011) 0.78
The perception of pain and its management in disorders of consciousness. Curr Pain Headache Rep (2013) 0.78
Immunological study of IFNbeta-1a-treated and untreated multiple sclerosis patients: clarifying IFNbeta mechanisms and establishing specific dendritic cell immunotherapy. Neuroimmunomodulation (2005) 0.77
Migraine attributed to genetic disorder: proposal of a new category. Cephalalgia (2011) 0.77
Evaluation of neuropsychological functions in patients with Friedreich ataxia before and after cognitive therapy. Funct Neurol (2010) 0.77
Epidemiology of stroke in the young. Stroke (2003) 0.77
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. BMC Neurol (2014) 0.77
Acute stroke admission and diagnostic procedures according to the hour and day of onset: the SIRIO collaborative data. Eur Neurol (2008) 0.77
Preventive non-pharmacological treatment and nitric oxide in chronic migraine. J Headache Pain (2005) 0.77
Neopterin production and tryptophan degradation during 24-months therapy with interferon beta-1a in multiple sclerosis patients. J Transl Med (2011) 0.77
An unexpected recovery from permanent vegetative state. Brain Inj (2007) 0.77
Brain white matter lesions in an italian family with charcot-marie-tooth disease. Eur Neurol (2004) 0.77
Sequence-Based analysis of the HLA-DRB1 polymorphism in Metalsa Berber and Chaouya Arabic-speaking groups from Morocco. Hum Immunol (2002) 0.77
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy. Cancer Immunol Immunother (2011) 0.77
Comorbidities: a key issue in patients with disorders of consciousness. J Neurotrauma (2015) 0.76
Moderate consumption of red wine and human platelet responsiveness. Thromb Res (2011) 0.76
Post-transplant development of C1q-positive HLA antibodies and kidney graft survival. Clin Transpl (2013) 0.76
Differential modulation of interleukin-6 expression by interleukin-1beta in neuronal and glial cultures. Eur Cytokine Netw (2003) 0.76
The Role of Gender-specific Cytokine Pathways as Drug Targets and Gender- specific Biomarkers in Personalized Cancer Therapy. Curr Drug Targets (2017) 0.76